Back to results
US 7,220,566 B2Granted
Subtilisin variants
AssigneesNovozymes A/S, Maxygen, Inc.
InventorsJon E. Ness, Mark Welch, Lorraine J. Giver, Joel R. Cherry, Torben V. Borchert, Jeremy Minshull
Life of this patent
Estimating the term…
Abstract
New subtilisin homologues (both nucleic acids and proteins) are provided. Compositions which include these new proteins, recombinant cells, shuffling methods involving the new homologues, antibodies to the new homologues, and methods of using the homologues are also provided.
Claims8
An isolated or recombinant polypeptide having endoprotease activity, which comprises an amino acid sequence that is at least 97% identical to SEQ ID NO:
- 134 over a comparison window of SEQ ID NO:
- 134, wherein the percent amino acid sequence identity is determined using the BLASTP program using the following parameters:
- a wordlength of 3 and an expectation of 10, and the BLOSUM62 scoring matrix.
Dependencies are inferred from the claim text.